{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:12:35Z","timestamp":1788639155150,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008076","name":"Ohio University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jbc.2023.105030","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:05:36Z","timestamp":1689041136000},"page":"105030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates"],"prefix":"10.1016","volume":"299","author":[{"given":"Reetobrata","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rich","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Sandbhor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Swegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia J.","family":"Caggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1161-6262","authenticated-orcid":false,"given":"Edward","family":"Brenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Neggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Kopchick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.105030_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/acel.12338","article-title":"Interventions to Slow aging in humans: are We Ready?","volume":"14","author":"Vd","year":"2015","journal-title":"Aging cell"},{"key":"10.1016\/j.jbc.2023.105030_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/apa.15948","article-title":"The history, physiology and treatment safety of growth hormone","volume":"111","author":"Tidblad","year":"2022","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.jbc.2023.105030_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat. Rev. Dis. primers"},{"key":"10.1016\/j.jbc.2023.105030_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/er.2018-00216","article-title":"Growth hormone deficiency: health and Longevity","volume":"40","author":"Aguiar-Oliveira","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jbc.2023.105030_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S2213-8587(18)30026-3","article-title":"The physiology of endocrine systems with ageing","volume":"6","author":"van den Beld","year":"2018","journal-title":"Lancet. Diabetes Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygcen.2014.11.004","article-title":"Autocrine\/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: an overview","volume":"220","author":"Harvey","year":"2015","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib7","doi-asserted-by":"crossref","first-page":"110068","DOI":"10.1016\/j.celrep.2021.110068","article-title":"Local non-pituitary growth hormone is induced with aging and facilitates epithelial damage","volume":"37","author":"Chesnokova","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2023.105030_bib8","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1530\/EJE-18-0018","article-title":"Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?","volume":"178","author":"Basu","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-021-01191-y","article-title":"Mice with gene alterations in the GH and IGF family","volume":"25","author":"Qian","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.jbc.2023.105030_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ghir.2015.08.004","article-title":"Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment","volume":"28","author":"Laron","year":"2016","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.jbc.2023.105030_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ghir.2006.10.007","article-title":"Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report","volume":"17","author":"Shevah","year":"2007","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.jbc.2023.105030_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2023.105030_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13506","article-title":"Growth hormone receptor gene disruption in mature-adult mice improves male insulin sensitivity and extends female lifespan","volume":"20","author":"Duran-Ortiz","year":"2021","journal-title":"Aging cell"},{"key":"10.1016\/j.jbc.2023.105030_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-019-0036-y","article-title":"Targeting growth hormone function: strategies and therapeutic applications","volume":"4","author":"Lu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2023.105030_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","article-title":"The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological Aspects","volume":"9","author":"Dehkhoda","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2001-0022","article-title":"Growth hormone receptor antagonists: discovery, development, and Use in patients with acromegaly","volume":"23","author":"Kopchick","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jbc.2023.105030_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1210\/jc.2002-022049","article-title":"Clinical review 166: growth hormone receptor antagonists","volume":"89","author":"Muller","year":"2004","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.105030_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/jme.0.0290011","article-title":"Pegvisomant: structure and function","volume":"29","author":"Pradhananga","year":"2002","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib19","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1210\/en.2015-1097","article-title":"The forgotten lactogenic activity of growth hormone: important implications for rodent studies","volume":"156","author":"Bartke","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2023.105030_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/me.2012-1297","article-title":"The role of prolactin receptor in GH signaling in breast cancer cells","volume":"27","author":"Xu","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib21","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1172\/JCI119820","article-title":"Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice","volume":"100","author":"Wennbo","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2023.105030_bib22","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/endo.140.8.7047","article-title":"The human growth hormone antagonist B2036 does not interact with the prolactin receptor","volume":"140","author":"Goffin","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2023.105030_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tem.2011.07.004","article-title":"Pleiotropic effects of growth hormone signaling in aging","volume":"22","author":"Bartke","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.105030_bib24","doi-asserted-by":"crossref","first-page":"dgz149","DOI":"10.1210\/clinem\/dgz149","article-title":"Long-acting growth hormone preparations - current Status and future considerations","volume":"105","author":"Miller","year":"2020","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.105030_bib25","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1073\/pnas.1100387108","article-title":"Optimized clinical performance of growth hormone with an expanded genetic code","volume":"108","author":"Cho","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.105030_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ped4.12358","article-title":"Long-acting growth hormone in 2022","volume":"7","author":"Steiner","year":"2023","journal-title":"Pediatr. Investig."},{"key":"10.1016\/j.jbc.2023.105030_bib27","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1530\/eje.0.148s027","article-title":"Pegvisomant: an advance in clinical efficacy in acromegaly","volume":"148","author":"Stewart","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/acs.bioconjchem.0c00208","article-title":"Long-acting human growth hormone receptor antagonists produced in E. coli and conjugated with polyethylene glycol","volume":"31","author":"Wang","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jbc.2023.105030_bib29","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1021\/acs.bioconjchem.0c00365","article-title":"Genetic code expansion enables site-specific PEGylation of a human growth hormone receptor antagonist through click Chemistry","volume":"31","author":"Tamshen","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jbc.2023.105030_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/acs.biomac.0c01105","article-title":"Enhanced bioactivity of a human GHR antagonist generated by Solid-Phase site-specific PEGylation","volume":"22","author":"Wang","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jbc.2023.105030_bib31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/me.2007-0424","article-title":"Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering","volume":"22","author":"Yang","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ijpharm.2013.06.022","article-title":"N-terminal mono-PEGylation of growth hormone antagonist: correlation of PEG size and pharmacodynamic behavior","volume":"453","author":"Wu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jbc.2023.105030_bib33","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1210\/en.2006-1170","article-title":"A\u00a0long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats","volume":"148","author":"Cox","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2023.105030_bib34","doi-asserted-by":"crossref","first-page":"25831","DOI":"10.3390\/ijms161025831","article-title":"Site-specific PEGylation of therapeutic proteins","volume":"16","author":"Dozier","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2023.105030_bib35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1006\/jmbi.1998.1669","article-title":"Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity","volume":"277","author":"Clackson","year":"1998","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2023.105030_bib36","first-page":"1716","article-title":"Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer","volume":"86","author":"Ross","year":"2001","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.105030_bib37","series-title":"PEGylated Protein Drugs: Basic Science and Clinical Applications","first-page":"187","article-title":"PEGylation of human growth hormone: strategies and properties","author":"Finn","year":"2009"},{"key":"10.1016\/j.jbc.2023.105030_bib38","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.bmc.2007.04.037","article-title":"C-Terminally PEGylated hGH-derivatives","volume":"15","author":"Peschke","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jbc.2023.105030_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.745843","article-title":"Cost-utility of acromegaly pharmacological treatments in a French context","volume":"12","author":"Brue","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2023.105030_bib40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.addr.2008.04.012","article-title":"Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance","volume":"60","author":"Thurber","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jbc.2023.105030_bib41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/acs.chemrev.7b00123","article-title":"Chemistry and Enzymology of disulfide cross-linking in proteins","volume":"118","author":"Fass","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jbc.2023.105030_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0003-2697(92)90460-O","article-title":"Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis","volume":"200","author":"Kurf\u00fcrst","year":"1992","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbc.2023.105030_bib43","series-title":"ImageJ","author":"Rasband","year":"1997"},{"key":"10.1016\/j.jbc.2023.105030_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2013.10.023","article-title":"Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment","volume":"441","author":"Sustarsic","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2023.105030_bib45","first-page":"3369","article-title":"Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in\u00a0vivo","volume":"0","author":"Basu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2023.105030_bib46","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/cancers12123640","article-title":"Growth hormone upregulates Mediators of melanoma drug efflux and epithelial-to-mesenchymal transition in\u00a0vitro and in\u00a0vivo","volume":"12","author":"Qian","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2023.105030_bib47","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/cancers11091352","article-title":"Growth hormone upregulates Melanocyte-Inducing transcription factor expression and activity via JAK2-STAT5 and SRC signaling in GH receptor-Positive human melanoma","volume":"11","author":"Basu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2023.105030_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12672-017-0292-7","article-title":"Growth hormone receptor knockdown sensitizes human melanoma cells to chemotherapy by attenuating expression of ABC drug efflux pumps","volume":"8","author":"Basu","year":"2017","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.jbc.2023.105030_bib49","doi-asserted-by":"crossref","first-page":"21579","DOI":"10.18632\/oncotarget.15375","article-title":"Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways","volume":"8","author":"Basu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2023.105030_bib50","article-title":"Autocrine\/paracrine actions of growth hormone in human melanoma cell lines","volume":"21","author":"Buckels","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.jbc.2023.105030_bib51","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105030_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8929715","article-title":"Protein PEGylation: navigating recombinant protein stability, aggregation, and bioactivity","volume":"2022","author":"Zuma","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jbc.2023.105030_bib53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/me.2010-0255","article-title":"Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex","volume":"25","author":"Xu","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jcem-53-2-344","article-title":"Plasma prolactin in acromegaly before and after treatment","volume":"53","author":"PABLO","year":"1981","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.105030_bib55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1530\/EJE-11-1119","article-title":"The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases","volume":"166","author":"Wang","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000173551","article-title":"Antiarrhythmic effects of Tiapamil on exercise-induced arrhythmias in patients with coronary artery disease","volume":"69","author":"Burkart","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.jbc.2023.105030_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10911-008-9064-x","article-title":"Historical Perspectives of prolactin and growth hormone as Mammogens, Lactogens and Galactagogues\u2014Agog for the future","volume":"13","author":"Trott","year":"2008","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.jbc.2023.105030_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.910978","article-title":"Prolactin: the third hormone in breast cancer","volume":"13","author":"Schuler","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2023.105030_bib59","doi-asserted-by":"crossref","first-page":"E1619","DOI":"10.1210\/jc.2011-1245","article-title":"Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma","volume":"96","author":"Wu","year":"2011","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.105030_bib60","doi-asserted-by":"crossref","first-page":"29465","DOI":"10.18632\/oncotarget.8781","article-title":"Human growth hormone and human prolactin function as autocrine\/paracrine promoters of progression of hepatocellular carcinoma","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2023.105030_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.598423","article-title":"Preparation of a growth hormone receptor\/prolactin receptor bispecific antibody antagonist which exhibited anti-cancer activity","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105030_bib62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10911-008-9066-8","article-title":"Rational design of competitive prolactin\/growth hormone receptor antagonists","volume":"13","author":"Tallet","year":"2008","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.jbc.2023.105030_bib63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ncpendmet0270","article-title":"Drug insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?","volume":"2","author":"Goffin","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.105030_bib64","doi-asserted-by":"crossref","first-page":"100588","DOI":"10.1016\/j.jbc.2021.100588","article-title":"A\u00a0novel peptide antagonist of the human growth hormone receptor","volume":"296","author":"Basu","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105030_bib65","first-page":"3735","article-title":"Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice","volume":"24","author":"Dagnaes-Hansen","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jbc.2023.105030_bib66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10549-006-9168-1","article-title":"The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth","volume":"98","author":"Divisova","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jbc.2023.105030_bib67","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/00498250802001834","article-title":"Differences in the total body clearance of lead compounds in the rat and mouse: impact on pharmacokinetic screening strategy","volume":"38","author":"McIntyre","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jbc.2023.105030_bib68","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.256.5064.1677","article-title":"Rational design of potent antagonists to the human growth hormone receptor","volume":"256","author":"Fuh","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.105030_bib69","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1016\/S0021-9258(18)53332-9","article-title":"Mechanism-based design of prolactin receptor antagonists","volume":"268","author":"Fuh","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105030_bib70","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/372478a0","article-title":"The X-ray structure of a growth hormone-prolactin receptor complex","volume":"372","author":"Somers","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105030_bib71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/B978-0-12-571148-7.50013-0","article-title":"The molecular basis for growth hormone-receptor interactions","volume":"48","author":"Wells","year":"1993","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.jbc.2023.105030_bib72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2017.05.009","article-title":"Prolactin receptor targeting in breast and prostate cancers: new insights into an old challenge","volume":"179","author":"Goffin","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2023.105030_bib73","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/sj.onc.1203349","article-title":"The role of prolactin and growth hormone in breast cancer","volume":"19","author":"Wennbo","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2023.105030_bib74","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.3390\/cancers13112662","article-title":"Suppression of breast cancer by small molecules that block the prolactin receptor","volume":"13","author":"Borcherding","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2023.105030_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41574-022-00702-6","article-title":"Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer","volume":"18","author":"Kopchick","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jbc.2023.105030_bib76","series-title":"Bioconjugate Techniques","first-page":"241","volume":"3","author":"Hermanson","year":"2013"},{"key":"10.1016\/j.jbc.2023.105030_bib77","first-page":"1249","article-title":"Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation","volume":"10","author":"Wang","year":"1996","journal-title":"Mol. Endocrinol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823020586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823020586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:40:15Z","timestamp":1762188015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823020586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0021925823020586"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105030","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"105030"}}